Digital Brands Group to Report Fourth Quarter and Fiscal Year 2023 Financial Results on Monday, April 15, 2024
AUSTIN, April 12, 2024 /PRNewswire/ -- Digital Brands Group, Inc. ("DBG") (NASDAQ: DBGI), a curated collection of luxury lifestyle, digital-first brands, will report financial results for the fourth quarter ended December 31, 2023 on Monday, April 15, 2023 at 4:30 p.m. ET.
Management will host a conference call on Monday, April 15 at 5:00 p.m. ET to discuss the results. The live conference call can be accessed by dialing 866-605-1828 from the U.S. or internationally. The conference I.D. code is 13746007 or referencing Digital Brands or via the web by using the following link: https://event.choruscall.com/mediaframe/webcast.html?webcastid=jg0EmFTQ.
About Digital Brands Group We offer a wide variety of apparel through numerous brands on a both direct-to-consumer and wholesale basis. We have created a business model derived from our founding as a digitally native-first vertical brand. We focus on owning the customer's "closet share" by leveraging their data and purchase history to create personalized targeted content and looks for that specific customer cohort.
Digital Brands Group, Inc. Company Contact Hil Davis, CEO Email: [email protected] Phone: (800) 593-1047
Smallstep Labs, a pioneer in streamlining secure device identity and champion of the Zero Trust approach to security, unveiled market data that shows an impressive 78% of the Fortune 100 companies actively engage with Smallstep's open source...
Aubex Therapeutics Inc., a pioneering biotechnology firm, announced its official launch, heralding a new era in the battle against cancer. Under the guidance of Board Member and Interim CEO, Jeffrey Glazer, Aubex's initial program is focused on novel...
AdGPT, the world's first fully automated ad creative tool for SMBs, today announced its launch out of stealth. The platform enables SMBs to create high-finish ads, without any previous advertising experience, that are optimized for digital...
Affini-T Therapeutics, Inc., a precision immunotherapy company unlocking the power of T cells against oncogenic driver mutations, today announced that data from its preclinical gene edited HLA-A*11:01 KRAS G12D (AFNT-212) and HLA-A*02:01 TP53 R175H T...
H2scan (www.h2scan.com), a leader in solid-state hydrogen sensing solutions, proudly announces a new milestone: more than 1.3 billion hours of field-proven service across a broad range of applications. This achievement includes 700 million hours in...
uLab Systems® announces the release of the uDesign® 9 treatment planning software, the AI-assisted platform designed exclusively for orthodontists to maximize their control over treatment and provide more aligner workflow flexibility than any other...
